Onconetix

Onconetix EPS

The Earnings per Share (EPS) of Onconetix (ONCO) as of Oct 18, 2026 is -4.28 USD. In the previous year, Earnings per Share (EPS) was -2,118.81 USD — a change of -99.80% (higher).

EPS

-4.28USD

YoY

-99.80%

Last updated:

Earnings per Share (EPS) of Onconetix is 2025 -4.28 USD. Earnings per Share (EPS) of Onconetix was 2024 -2,118.81 USD. It decreases by -99.80% higher compared to the previous year.

The Onconetix EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
-0.37 USD
Jan 1, 2020
-0.53 USD
Jan 1, 2021
-299.77 USD
Jan 1, 2022
-854.77 USD
Jan 1, 2023
-67.03 USD
Jan 1, 2024
-2,118.81 USD
Jan 1, 2025
-4.28 USD
The Onconetix EPS history
YEAREPSYoY
-4.28USD-99.80%
-2,118.81USD+3,060.97%
-67.03USD-92.16%
-854.77USD+185.14%
-299.77USD+56,124.92%
-0.53USD+45.48%
-0.37USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Onconetix Stock analysis

What does Onconetix do? Onconetix Inc, based in Cincinnati, Ohio, is a biotechnology company operating in the Health Care sector. It focuses on developing transformational vaccines to prevent infectious diseases, including a streptococcus pneumonia vaccine for childhood ear infections and pneumonia in the elderly, a universal flu vaccine, and a Chlamydia vaccine developed in collaboration with the University of Texas Health Science Center. The company, listed on February 18, 2022, employs 12 full-time staff. Onconetix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onconetix stock

Earnings per Share (EPS) of Onconetix is -4.28 USD in 2025.

Earnings per Share (EPS) of Onconetix changed from -2,118.81 USD to -4.28 USD, representing a -99.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Onconetix since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Onconetix

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Onconetix